Viewing Study NCT06884293


Ignite Creation Date: 2025-12-25 @ 1:05 AM
Ignite Modification Date: 2026-01-06 @ 9:22 PM
Study NCT ID: NCT06884293
Status: RECRUITING
Last Update Posted: 2025-05-14
First Post: 2025-03-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module